The late gene network is centered on ERBB2, a member of the epidermal growth factor (EGF) family of receptor tyrosine kinases, and one of the major molecular prognostic and predictive markers in breast cancer (Figure 2B). The gene discussed is ERBB2; the disease is breast cancer.